Back to news

December 9, 2020 | International, Naval

Saab to equip Bulgarian Navy’s new patrol vessels

December 8, 2020 - Saab has signed a contract with the German shipbuilding company Lürssen and received an order to provide and integrate the combat system for the Bulgarian Navy's new Multipurpose Modular Patrol Vessels, MMPV.

Lürssen is the prime contractor to the Bulgarian Ministry of Defence, and will build the two new patrol vessels at the Bulgarian shipyard MTG Dolphin JSC.

The vessels are scheduled to be delivered to the end customer between 2025 and 2026.

“We are proud to continue our successful cooperation with Lürssen. We look forward to contributing to strengthen Bulgaria's defence and national security for years to come with our proven technology and solid naval combat system expertise”, says Anders Carp, deputy CEO of Saab and head of business area Surveillance.

Saab will carry out the work at its premises in Sweden, Denmark, Australia and South Africa.

For further information, please contact:
Saab Press Centre,
+46 (0)734 180 018
Twitter: @Saab

Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers' changing needs.

View source version on Saab:

On the same subject

  • Pentagon budget request increases R&D funding, cuts legacy planes

    February 11, 2020 | International, Aerospace, Naval, Land, C4ISR, Security

    Pentagon budget request increases R&D funding, cuts legacy planes

    By: Aaron Mehta WASHINGTON — U.S. President Donald Trump's defense budget request for fiscal 2021 includes major investments in research and development portfolios as well as “crucial” technologies as part of what the Pentagon is branding an “irreversible implementation” of the National Defense Strategy. However, the budget also features overall cuts to the Army and Navy top lines, as well as the divestment of legacy platforms from the Air Force. The president is requesting $705 billion for the Defense Department, including $69 billion in overseas contingency operations, or OCO, wartime funds. Total national security spending, including for the National Nuclear Security Administration and other outside agencies, is $740 billion, as set by a congressional budget agreement last year. Although not included in the budget documents, total top-line projections over the Future Years Defense Program, or FYDP, are $722 billion in FY22, $737 billion in FY23, $753 billion in FY24 and $768 billion in FY25, according to a senior defense official. Service budget top lines are $178 billion for the Army, a drop by $462 million from FY20 enacted levels; $207 billion for the Navy, down $1.9 billion from FY20; and $207 billion for the Air Force, up $1.7 billion from FY20. The budget also requests $113 billion for defensewide efforts, which includes the so-called fourth estate agencies, down $6.5 billion from FY20. Overall procurement funding sits at $136.9 billion. The OCO request of $69 billion is down dramatically from last year's $164 billion, and it comes in three flavors: $20.5 billion in “direct war requirements,” or funding for combat operations that will end at some point in locations like Iraq and Syria. $32.5 billion in “enduring requirements,” which covers funding for the sustainment of bases, as well as pots of money like the European Deterrence Initiative. $16 billion in “OCO for base,” a funding mechanism for money that could be in the base budget but is classified as OCO for the purpose of skirting budget caps imposed by Congress. Projection for OCO funding falls $20 billion in FY22 and FY23, and then to $10 billion for FY24 and FY25, as “certain OCO costs” are absorbed by the base budget, according to the White House's summary tables. There's no nondefense discretionary OCO proposed for FY21 or the out years. “This is a budget that makes difficult choices but they are actually choices that support the National Defense Strategy,” a senior defense official said on condition of anonymity ahead the budget rollout. “We can't have the best of everything in all areas,” the official added. “The low-hanging fruit is gone.” Among the tough choices: retiring 17 B-1 bombers, 44 A-10 planes, 24 Global Hawk drones, as well as 16 KC-10 and 13 KC-135 tankers from the Air Force. “When you look at these aircraft, they disproportionately take too much of the readiness account. That's where we've got to go,” the official said. “Those are really the tough choices we had to make. Because we can now take the additional manpower, the [spare parts], all those things we need to make those other aircraft more operationally available and have more flight hours available in the mission we need them to do.” Congress usually revises presidential budget submissions substantially before passing them into law. A prime target for lawmakers this year will be the Trump administration's favoritism for defense spending over nondefense, which contradicts the rough parity between two that's characterized bipartisan budget deals in recent years. Congress will also likely upend the administration's FY21 proposal to cut the nondefense base budget by 5.1 percent while adding 0.08 percent to the base defense budget. There are slim odds for Trump's proposal extending budget caps — set to expire next year — through 2025, wherein defense would increase by roughly 2 percent each year as nondefense discretionary decreases 2 percent each year. ‘Irreversible' Budget documents were branded with the phrase “irreversible implementation of the National Defense Strategy,” a notable signal in an election year that, should Trump not be reelected, could result in major changes to the national budget and American strategy come January. The branding in support of the NDS can be found throughout the document, even at lower levels. For instance, the Pentagon's security cooperation account has been rebranded the “NDS Implementation (NDS-I) account.” Missing from the budget request are funds for Trump's border wall with Mexico. However, CNN reported this weekend that “billions” of defense dollars will be going toward the wall effort, with an announcement expected later this week. Key defense spending accounts break down like this: Mission-support activities: $66.8 billion Aircraft and related systems: $56.9 billion Shipbuilding and maritime systems: $32.2 billion Missiles and munitions: $21.3 billion Space-based systems: $15.5 billion Ground systems: $13 billion C4I systems: $11.9 billion Missile defeat and defense programs: $11.6 billion The department is requesting $106.6 billion to fund research, development, test and evaluation (RDT&E) efforts, an increase of $2 billion over the FY20 enacted figures — something another senior defense official called the “largest [RDT&E] request in over 70 years.” Funding for that came from savings from the defensewide review, which found $5.7 billion in money to reprogram in FY21, as well as the retirement of older platforms. Four “crucial” technologies are now bunched together under a new acronym — ACE, which stands for advanced capability enablers: hypersonics at $3.2 billion, microelectronics/5G at $1.5 billion, autonomy at $1.7 billion, and artificial intelligence at $800 million. However, for the second straight year, science and technology funding for early technology development (the Pentagon's 6.1, 6.2 and 6.3 accounts) is requested at $14.1 billion; that includes $3.5 billion for the Defense Advanced Research Projects Agency. Congress plussed that funding to $16.1 billion in FY20 enacted levels, meaning the request here is $2 billion less than what the Pentagon received this current year. Cyber activates total $9.8 billion, including $5.4 billion for cybersecurity-focused projects. The rest of the funding goes toward supporting defensive cyber operations.

  • Reinventing Drug Discovery and Development for Military Needs

    November 30, 2018 | International,

    Reinventing Drug Discovery and Development for Military Needs

    Flying at 50,000 feet, diving deep in the ocean, or hiking for miles with gear through extreme climates, military service members face conditions that place unique burdens on their individual physiology. The potential exists to develop pharmacological interventions to help service members complete their toughest missions more safely and efficiently, and then recover more quickly and without adverse effects, but those interventions must work on complex physiological systems in the human body. They will not be realized under the prevailing system of drug discovery and development with its focus on engaging single molecular targets. DARPA created the Panacea program to pursue the means of rapidly discovering, designing, and validating new, multi-target drugs that work with the body's complexity to better support the physiological resilience and recovery of military service members. The premise of Panacea is that the physiological systems of the human body work in complex and highly integrated ways. Drugs exert effects on our bodies by physically interacting with and changing the functional state of biomolecules that govern the functions of cells and tissues. Most drugs target proteins, which are the principle cellular workhorses. Ideally, drugs would target multiple proteins simultaneously to exert precise, network-level effects. One major problem facing the drug development community is that the functional proteome — the complete collection of proteins and their roles in signaling networks — is largely dark to science. Despite being able to identify many of the proteins within a cell, researchers do not have a firm grasp on everything those proteins do and how they interact to affect physiology. Due to this sparsity of structural and functional knowledge, the state of the art in drug development — what Panacea seeks to transform — is to engage only a very small fraction of known protein targets to achieve an effect. In fact, today's approach to drug design singles out individual proteins in certain cells. That hyper-specificity is an attempt to minimize the risk of side effects and speed time to market, but it also yields a thin stream of drugs, many of which have similar mechanisms and relatively muted effectiveness compared to what might be achieved using a multi-target, systems-based approach. “The current roster of drugs approved by the U.S. Food and Drug Administration only targets about 549 proteins, yet the body can produce more than six million different protein variants,” said Tristan McClure-Begley, the Panacea program manager. “The opportunity space for pharmacological intervention is vast and effectively untapped, but to access it we need new technology for understanding and targeting the human functional proteome.” Panacea will address the lack of functional knowledge about the proteome. DARPA's call to the research community is to consider complex physiological conditions relevant to military service members — for instance, metabolic stress during extreme endurance missions or pain and inflammation after injury; investigate the molecular mechanisms underlying those conditions; identify multiple, key molecular targets involved; and develop novel medicinal chemistry approaches to synthesize interventions that modulate those targets. DARPA believes that multi-target drugs will deliver safer and more efficacious solutions to military requirements for readiness and recovery over state-of-the-art interventions. “Many of the most successful drugs produced in the past were found rather than made, and we knew what they did long before we knew how they did it,” McClure-Begley said. “To deliver improved interventions, we need to get to a place where we can investigate all of the potential proteins at play for a given condition and then prioritize sets of protein targets and signaling networks to effectively modulate physiological systems, regardless of what prior knowledge exists about those targets.” The Panacea program aims to generate initial proof of concept for this new direction in drug discovery and development. Research will primarily involve animal models, human cell derived organoids, and high-throughput cell culture models. However, to support eventual transition to humans, DARPA will work with federal agencies to develop a regulatory pathway for future medical use. By the end of the five-year program, DARPA will require teams to submit novel drug candidates to the U.S. Food and Drug Administration for review as an Investigational New Drug or for Compassionate Use. DARPA will hold a Proposers Day on December 14, 2018, in Arlington, Virginia, to provide more information about Panacea and answer questions from potential proposers. For details of the event, including registration requirements, visit A forthcoming Broad Agency Announcement will fully describe the program structure and objectives.


    September 28, 2018 | International, Aerospace


    Supply Chain Competition Continues to Reduce Cost and Enhance Capability FORT WORTH, Texas, Sept. 27, 2018 /PRNewswire/ -- Lockheed Martin (NYSE: LMT) has selected Harris Corporation (NYSE: HRS) to develop and deliver the next generation Integrated Core Processor (ICP) for the F-35 fighter jet. The Lockheed Martin-led competition within the F-35 supply chain will significantly reduce cost and enhance capability. The F-35's ICP acts as the brains of the F-35, processing data for the aircraft's communications, sensors, electronic warfare, guidance and control, cockpit and helmet displays. "We are aggressively pursuing cost reduction across the F-35 enterprise and, after conducting a thorough review and robust competition, we're confident the next generation Integrated Core Processor will reduce costs and deliver transformational capabilities for the warfighter," said Greg Ulmer, Lockheed Martin vice president and general manager of the F-35 program. "The next generation Integrated Core Processor for the F-35 will have positive benefits for all customers in terms of life cycle cost, capability, reliability and more." The new Integrated Core Processor is a key element of the planned "Technology Refresh 3" modernization that takes advantage of fast evolving computing power to ensure the advanced F-35 remains ahead of evolving threats. Additional elements in the tech refresh include the Panoramic Cockpit Display Electronic Unit and Aircraft Memory System, which were also recompeted and awarded to Harrislast year. Reduce Costs, Increased Performance The Harris-built ICP will be integrated into F-35 aircraft starting with Lot 15 aircraft, expected to begin deliveries in 2023. The next generation ICP system is targeted to generate the following results compared to the current system: 75 percent reduction in unit cost 25 times increase in computing power to support planned capability enhancements Greater software stability, higher reliability, and increased diagnostics resulting in lower sustainment costs An Open System Architecture to enable the flexibility to add, upgrade and update future capabilities "The new F-35 ICP will pave the way for system scalability well into the future," said Ed Zoiss, president, Harris Electronic Systems. "Open systems are the future of avionics and Harris has invested substantial R&D to deliver more affordable and higher performance solutions than would have been possible using proprietary technology." Supply Chain Optimization The ICP selection comes on the heels of Lockheed Martin's selection of Raytheon for the Next Gen Distributed Aperture System, which will reduce lifecycle costs by more than $3 billion, enhance reliability and increased capability. "With production ramping up and the operational fleet growing fast, we are looking at every layer of our global supply chain to find opportunities to increase capacity, reduce production and sustainment costs, improve parts reliability and enhance capabilities," said Ulmer. In addition to competition, the company is transitioning several F-35 suppliers to longer term Performance Based Logistics contracts to enhance parts availability and reduce sustainment costs. Previously under annual contracts, the new 5-year PBLs allow each supplier to make longer term investments and actions to reduce costs and improve efficiencies. With radar evading stealth technology, advanced sensors, enhanced weapons capacity, supersonic speed and superior range, the F-35 is the most lethal, survivable and connected fighter aircraft ever built. More than a fighter jet, the F-35's ability to collect, analyze and share data is a powerful force multiplier enhancing all airborne, surface and ground-based assets in the battlespace and enabling men and women in uniform to execute their mission and come home safe. For additional information, visit About Lockheed Martin Headquartered in Bethesda, Maryland, Lockheed Martin is a global security and aerospace company that employs approximately 100,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services. This year the company received three Edison Awards for ground-breaking innovations in autonomy, satellite technology and directed energy. About Harris Corporation Harris Corporation is a leading technology innovator, solving customers' toughest mission-critical challenges by providing solutions that connect, inform and protect. Harris supports government and commercial customers in more than 100 countries and has approximately $6 billion in annual revenue. The company is organized into three business segments: Communication Systems, Space and Intelligence Systems, and Electronic Systems. Learn more at SOURCE Lockheed Martin Aeronautics Company

All news